Insider Stock Trading History of Baker Bros. Investments, L.p.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Baker Bros. Investments, L.p. since year 2005. The trader's CIK number is 1551136. At the time of this reporting, Baker Bros. Investments, L.p. is the Director of Genomic Health Inc . (stock ticker symbol GHDX). See this page for all insider trading activities at Genomic Health Inc .

Note that in the past Baker Bros. Investments, L.P. also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Baker Bros. Investments, L.p. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-08-15 GHDX Genomic Health Inc Buy 100,000 27.02 2,701,600
2013-08-01 BCRX Biocryst Pharmaceuticals Inc Buy 1,136,364 4.40 5,000,001

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Baker Bros. Investments, L.p. (Director of Genomic Health Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.